We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

GNLN:NASDAQGreenlane Holdings, Inc. Analysis

Data as of 2026-06-22 - not real-time

$2.57

Latest Price

9/10Risk

Risk Level: High

Executive Summary

Greenlane Holdings (GNLN) trades at $2.57, far below its DCF‑derived fair value of $44.55, suggesting extreme price discount. However, the stock is entrenched in a bearish technical environment – the 20‑day SMA (3.10) sits well under the 50‑day SMA (3.80) and far below the 200‑day SMA (14.46), RSI is at 35 indicating oversold conditions, and the MACD histogram remains negative. Volatility is high (≈81% 30‑day) and beta exceeds 2.5, amplifying price swings. Fundamentally, the company reports negative earnings, a -95% max drawdown, and no dividend, while operating cash flow is negative and margins are in the double‑digit negatives.
The only bright spot is the recent Q1 2026 press release highlighting a 44% increase in BERA‑per‑share holdings, which may hint at incremental upside from its blockchain‑staking activities. Nonetheless, the combination of distressed financials, high beta, and sector‑specific regulatory exposure (tobacco and crypto) makes the stock a high‑risk play despite its apparent undervaluation.

Market Outlook

Short Term

< 1 year
Cautious
Model confidence: 6/10

Key Factors

  • Bearish technical pattern (SMA crossover, MACD below signal)
  • High short‑term volatility and beta
  • Price near immediate support at $2.40

Medium Term

1–3 years
Neutral
Model confidence: 5/10

Key Factors

  • Potential upside from BERA staking growth
  • Continued earnings weakness and negative cash flow
  • Uncertain regulatory landscape for tobacco and crypto

Long Term

> 3 years
Positive
Model confidence: 7/10

Key Factors

  • Massive valuation gap versus DCF fair value
  • Strategic pivot toward blockchain infrastructure could improve margins
  • Low price‑to‑book (0.03) and price‑to‑sales (0.49) offer deep cushion if turnaround occurs

Key Metrics & Analysis

Financial Health

Revenue Growth-69.50%
P/E Ratio-0.5
ROE-272.88%
ROA-71.83%
P/B Ratio0.0
Op. Cash Flow$-17645000
Free Cash Flow$1.1M

Technical Analysis

TrendBearish
RSI35.7
Support$2.40
Resistance$3.54
MA 20$3.10
MA 50$3.80
MA 200$14.46
MACDBearish
VolumeStable
Fear & Greed Index91.46

Valuation

Fair Value$44.55
GradeUndervalued
TypeValue

Risk Assessment

Beta2.51
Volatility81.01%
Sector RiskMedium
Reg. RiskHigh
Geo RiskLow
Currency RiskLow
Liquidity RiskHigh

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.